William R. Miller

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial

Matthew J. Ellis, Andrew Coop, Baljit Singh et al. · Journal of Clinical Oncology · 2001 · 1.1K citations · Full text

A standard curve based method for relative real time PCR data processing

Alexey A. Larionov, Andreas Krause, William R. Miller · BMC Bioinformatics · 2005 · 954 citations · Full text

Assessing drinkers' motivation for change: The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES).

William R. Miller, J. Scott Tonigan · Psychology of Addictive Behaviors · 1996 · 855 citations

Behavioral Sciences, Substance Use, Change Readiness +11

Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update

Manfred Kaufmann, Gabriel N. Hortobágyi, Aron Goldhirsch et al. · Journal of Clinical Oncology · 2006 · 718 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +13

Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics

Michael J. Ellis, Yu Tao, Jingqin Luo et al. · JNCI Journal of the National Cancer Institute · 2008 · 651 citations · Full text